Former Pfizer CEO, finance chief step back from Starboard’s activist campaign
The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was
Read MoreThe about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was
Read MoreJohnson & Johnson said it will discontinue a mid-stage field study evaluating the efficacy of its experimental pill for the
Read MoreA breakup would be a stunning reversal for CVS, which has spent tens of billions of dollars on acquisitions to
Read MoreThe twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S.
Read MoreThe FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's
Read MoreSwiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read MoreBristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind
Read MoreThe results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.Â
Read MoreDemand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily
Read More